Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.10, $0.22 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.